PRESS RELEASE published on 02/06/2024 at 07:30, 9 months 15 days ago APONTIS PHARMA successfully completes performance and efficiency improvement program APONTIS PHARMA successfully completes performance and efficiency improvement program, reducing headcount and expenses. New go-to-market approach for Single Pill combinations to start on 1 March 2024 Pharmaceutical Company Efficiency APONTIS PHARMA Performance Improvement Single Pill Combinations
PRESS RELEASE published on 11/09/2023 at 07:30, 1 year ago APONTIS PHARMA presents details of the restructuring and efficiency program – Nine-month figures for 2023 and new sales and earnings forecast for 2023 published
PRESS RELEASE published on 11/08/2023 at 20:00, 1 year ago EQS-Adhoc: APONTIS PHARMA AG with new forecast 2023 and details on announced restructuring program
PRESS RELEASE published on 10/07/2023 at 00:54, 1 year 1 month ago EV Nickel Issues Shares to Rogue and, Rogue Update
PRESS RELEASE published on 10/04/2023 at 13:30, 1 year 1 month ago EVNi Clean Nickel(TM) R&D - Carbon Capture Results Beat Expectations, Great Potential for Carbon Mineralization and Storage – Advancing to Pilot Plant Testing
PRESS RELEASE published on 09/27/2023 at 13:30, 1 year 1 month ago EVNi Clean Nickel(TM) R&D- Bioleaching Successfully Produces End-Product for Battery Plants – Progressing now to Pilot Plant Testing
PRESS RELEASE published on 09/16/2023 at 04:15, 1 year 2 months ago EV Nickel Completes Closing of Oversubscribed C$2.1M Private Placement
PRESS RELEASE published on 09/14/2023 at 13:30, 1 year 2 months ago EV Nickel to Close Oversubscribed Private Placement of C$2.1M
PRESS RELEASE published on 09/12/2023 at 13:30, 1 year 2 months ago EV Nickel Provides Update on Upsized Private Placement
PRESS RELEASE published on 08/10/2023 at 07:30, 1 year 3 months ago APONTIS PHARMA confirms preliminary figures – H1 2023 sales and earnings decline
Published on 11/22/2024 at 00:00, 5 hours 16 minutes ago Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 7 hours 11 minutes ago Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 7 hours 26 minutes ago Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 9 hours 1 minute ago Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 9 hours 6 minutes ago For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 19:01, 10 hours 15 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 10 hours 40 minutes ago Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 11 hours 18 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 11 hours 24 minutes ago LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 11 hours 25 minutes ago 2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.
Published on 11/21/2024 at 06:58, 22 hours 18 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 9 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 11 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 11 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 21 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
